Diabetes and Endocrinology

Welcome Message

We are delighted to welcome you to the DIABETES MEET 2027, the 7^th Annual Summit on Diabetes and Endocrinology, taking place on March 23–24, 2027, in Paris, France. This premier international summit brings together endocrinologists, diabetologists, researchers, clinicians, healthcare professionals, and industry experts to share knowledge, discuss emerging research, and explore the latest advancements in diabetes and endocrine care.

Under the theme, "Bridging Science and Care in Diabetes and Endocrinology," the summit will feature keynote lectures, scientific sessions, panel discussions, and networking opportunities, fostering collaboration and innovation to advance research, clinical practice, and patient care.

We look forward to welcoming you to Paris for an engaging and inspiring scientific experience.

Target Audience

• Endocrinologists

• Diabetologists

• Diabetes Specialists

• Internal Medicine Physicians

• General Physicians

• Pediatric Endocrinologists

• Obesity & Metabolic Disorder Specialists

• Thyroid Specialists

• Hormone Disorder Specialists

• Clinical Researchers

• Diabetes Educators

• Nutritionists & Dietitians

• Academic Researchers & Faculty

• Healthcare Practitioners

• Endocrinology Residents

• Clinical Fellows

• Pharmaceutical & Biotechnology Industry Professionals

• Medical Device & Diabetes Technology Expert

• Next-Generation Healthcare Solutions

About Conference

The 7^th Annual Summit on Diabetes and Endocrinology (DIABETES MEET 2027) will be held on March 23–24, 2027, in Paris, France, under the theme "Bridging Science and Care in Diabetes and Endocrinology." This premier international summit will bring together endocrinologists, diabetologists, researchers, clinicians, academicians, healthcare professionals, and industry experts to exchange knowledge, present pioneering research, and discuss the latest developments in diabetes and endocrine science.

DIABETES MEET 2027 will feature keynote lectures, scientific sessions, panel discussions, poster presentations, workshops, and networking opportunities, providing a collaborative platform for scientific exchange and professional development. The summit will cover a wide range of topics, including diabetes management, obesity and metabolic disorders, thyroid diseases, reproductive endocrinology, pediatric endocrinology, endocrine oncology, precision medicine, and emerging therapeutic innovations.

Why To Attend?

DIABETES MEET 2027 offers a unique opportunity to engage with a global community of endocrinologists, diabetologists, researchers, clinicians, academicians, healthcare professionals, and industry experts dedicated to advancing diabetes and endocrine care. The summit brings together renowned experts from around the world to share groundbreaking research, clinical expertise, and the latest innovations in endocrinology.

Key topics include diabetes management, obesity and metabolic disorders, thyroid diseases, adrenal and pituitary disorders, reproductive and pediatric endocrinology, endocrine oncology, precision medicine, digital health, and emerging therapeutic approaches. Participants will gain valuable insights into the latest scientific discoveries, evidence-based clinical practices, and innovative technologies that are shaping the future of diabetes and endocrine care.

Sessions And Tracks

Track 1: Advances in Diabetes Management and Treatment

Diabetes management is rapidly evolving with continuous advancements in therapeutic approaches, clinical strategies, and personalized care models. This track will explore the latest developments in the prevention, diagnosis, and management of diabetes across diverse patient populations. It will highlight innovative medications, integrated care approaches, and evidence-based strategies to achieve optimal glycemic control while improving patient outcomes.

• Novel Antidiabetic Medications
• Glycemic Control Strategies
• Personalized Diabetes Care

Track 2: Diabetes Technology and Digital Health

Digital transformation is revolutionizing diabetes care through advanced monitoring systems, artificial intelligence, and connected healthcare solutions. This track will focus on emerging technologies that enhance disease monitoring, treatment decisions, and patient engagement. It will highlight innovations in glucose monitoring, automated insulin delivery systems, and digital health platforms that are shaping the future of personalized diabetes management.

• Continuous Glucose Monitoring (CGM)
• Insulin Pump Technologies
• Artificial Intelligence in Diabetes Care
• Digital Diabetes Management Platforms

Track 3: Diabetic Complications and Clinical Management

Diabetes-related complications remain a major global healthcare concern requiring early detection, prevention, and effective clinical management. This track will discuss advances in diagnosing and treating diabetes-associated complications through multidisciplinary approaches. It will highlight emerging therapies, innovative technologies, and strategies aimed at reducing complications and improving long-term patient outcomes.

• Diabetic Retinopathy
• Diabetic Neuropathy
• Diabetic Nephropathy
• Cardiovascular Complications

Track 4: Endocrine Disorders and Hormonal Health

Endocrine disorders affect multiple physiological systems and require advanced diagnostic and therapeutic approaches for effective management. This track will explore recent developments in hormonal disorders, endocrine regulation, and innovative treatment strategies. Discussions will focus on improving diagnosis, advancing clinical care, and understanding complex endocrine conditions through evidence-based approaches. Experts will highlight emerging research and technologies that are transforming endocrine healthcare.

• Thyroid Disorders

• Adrenal and Pituitary Disorders

• Hormonal Imbalances

• Endocrine Function Disorders

Track 5: Obesity, Metabolism and Weight Management

Obesity and metabolic disorders are major contributors to the increasing global burden of diabetes and related complications. This track will highlight advancements in obesity management, metabolic health, and multidisciplinary approaches to weight control. It will explore lifestyle interventions, pharmacological therapies, and innovative treatment strategies. The session will emphasize the importance of prevention and personalized approaches to improve metabolic outcomes.

• Obesity Management Strategies

• Metabolic Syndrome

• Bariatric Medicine

• Nutrition and Lifestyle Interventions

Track 6: Diabetes Prevention and Public Health

Prevention and early intervention play a crucial role in reducing the worldwide impact of diabetes. This track will focus on population-based strategies, screening programs, and public health initiatives aimed at preventing diabetes and improving community health outcomes. It will explore approaches for early identification, risk reduction, and effective disease management. Experts will discuss global challenges and opportunities in diabetes prevention.

• Diabetes Prevention Programs

• Early Detection and Screening

• Community Diabetes Care

• Global Health Initiatives

Track 7: Insulin Therapy and Emerging Diabetes Treatments

Insulin therapy remains an essential component of diabetes management with continuous advancements in delivery systems and treatment approaches. This track will explore innovations in insulin therapy, new formulations, and emerging therapeutic options for improved diabetes control. Discussions will include strategies to optimize insulin use and enhance patient outcomes. Experts will highlight future directions in diabetes treatment.

• Advanced Insulin Delivery Systems

• Smart Insulin Technologies

• Insulin Optimization Strategies

• Emerging Diabetes Therapies

Track 8: Precision Medicine in Diabetes and Endocrinology

Precision medicine is transforming diabetes and endocrine care by enabling individualized diagnosis and targeted treatment approaches. This track will explore advances in genetics, biomarkers, and personalized healthcare strategies. It will highlight how molecular insights are improving disease classification and therapeutic decision-making. The session will discuss future opportunities in personalized endocrine medicine.

• Genetic Approaches in Diabetes

• Biomarkers and Personalized Therapy

• Molecular Endocrinology

• Precision Healthcare Models

Track 9: Pediatric Diabetes and Endocrinology

Pediatric diabetes and endocrine disorders require specialized approaches to support healthy growth and development. This track will discuss advances in the diagnosis, treatment, and management of endocrine conditions affecting children and adolescents. It will focus on innovative therapies, early intervention strategies, and long-term care approaches. Experts will highlight challenges and advancements in pediatric endocrine health.

• Childhood Diabetes Management

• Growth and Puberty Disorders

• Pediatric Obesity

• Adolescent Endocrine Care

Track 10: Cardiometabolic Health and Diabetes

Diabetes is closely associated with cardiovascular risks and metabolic complications requiring integrated healthcare approaches. This track will explore strategies for managing cardiometabolic disorders and reducing disease-related risks. Discussions will focus on cardiovascular protection, metabolic control, and emerging therapies. The session will highlight collaborative approaches for improving long-term patient outcomes.

• Diabetes and Cardiovascular Disease

• Hypertension Management

• Lipid Disorders

• Cardiometabolic Risk Reduction

Track 11: Diabetic Kidney Disease and Renal Endocrinology

Diabetic kidney disease is one of the most serious complications associated with diabetes, requiring early diagnosis and effective management. This track will highlight advances in renal protection, kidney disease prevention, and innovative treatment strategies. It will discuss the relationship between diabetes, kidney function, and metabolic health. Experts will explore approaches to improve renal outcomes in diabetic patients.

• Diabetic Nephropathy

• Chronic Kidney Disease Management

• Renal Protection Strategies

• Kidney–Metabolism Interactions

Track 12: Nutrition, Lifestyle and Diabetes Care

Nutrition and lifestyle modification remain fundamental components of diabetes prevention and management. This track will explore evidence-based approaches involving diet, exercise, and behavioral strategies for improving metabolic health. It will highlight personalized nutrition plans and lifestyle interventions. Experts will discuss practical approaches for achieving sustainable diabetes control.

• Medical Nutrition Therapy

• Exercise and Diabetes Management

• Lifestyle Modification

• Behavioral Health Approaches

Track 13: Thyroid Disorders and Endocrine Innovations

Thyroid disorders represent some of the most common endocrine conditions affecting global health. This track will explore advancements in thyroid diagnosis, treatment approaches, and innovative therapeutic strategies. Discussions will cover emerging technologies and improved management practices. Experts will highlight current research and future developments in thyroid care.

• Hypothyroidism and Hyperthyroidism

• Thyroid Cancer

• Thyroid Imaging and Diagnostics

• Emerging Thyroid Therapies

Track 14: Reproductive Endocrinology and Diabetes

Hormonal disorders and diabetes significantly influence reproductive health and overall wellbeing. This track will focus on advances in reproductive endocrinology, fertility management, and metabolic disorders affecting reproductive outcomes. It will explore clinical challenges and innovative treatment approaches. Experts will discuss strategies for improving reproductive healthcare.

• Polycystic Ovary Syndrome (PCOS)

• Diabetes in Pregnancy

• Fertility and Hormonal Disorders

• Women’s Endocrine Health

Track 15: Endocrine Oncology

Endocrine cancers require advanced diagnostic techniques and multidisciplinary treatment strategies. This track will explore innovations in endocrine tumor research, targeted therapies, and personalized cancer management. Discussions will focus on improving diagnosis and treatment outcomes. Experts will highlight emerging developments in endocrine oncology.

• Thyroid Cancer Management

• Neuroendocrine Tumors

• Molecular Oncology

• Targeted Endocrine Therapies

Track 16: Clinical Trials and Translational Diabetes Research

Clinical research plays a vital role in developing new therapies and improving diabetes and endocrine care. This track will highlight clinical trials, translational research, and evidence-based approaches driving medical innovation. It will explore strategies for translating scientific discoveries into clinical applications. Experts will discuss future directions in diabetes research.

• Clinical Trial Development

• Translational Medicine

• Evidence-Based Diabetes Care

• Research Innovations

Track 17: Artificial Intelligence and Digital Transformation in Endocrinology

Artificial intelligence and digital technologies are reshaping the future of diabetes and endocrine healthcare. This track will explore the role of AI, machine learning, and digital solutions in diagnosis, monitoring, and personalized treatment planning. It will highlight opportunities and challenges associated with technology-driven healthcare. Experts will discuss future innovations in digital endocrinology.

• AI in Disease Prediction

• Machine Learning Applications

• Digital Health Solutions

• Smart Healthcare Technologies

Track 18: Pharmacology and Therapeutic Innovations

Advances in pharmacology continue to transform the management of diabetes and endocrine disorders. This track will explore emerging medications, therapeutic approaches, and innovative drug development strategies. Discussions will focus on improving treatment effectiveness and patient safety. Experts will highlight future directions in endocrine pharmacotherapy.

• GLP-1 Receptor Agonists

• SGLT2 Inhibitors

• Novel Drug Development

• Advanced Therapeutic Strategies

Track 19: Endocrinology Education and Professional Development

Continuous education and professional development are essential for advancing excellence in endocrine healthcare. This track will focus on innovative learning methods, clinical training, and leadership development. It will highlight strategies for improving healthcare education and building future generations of specialists. Experts will discuss evolving approaches in medical training.

• Medical Education Innovations

• Clinical Training Programs

• Continuing Professional Development

• Leadership in Healthcare

Track 20: Future Directions in Diabetes and Endocrinology

The future of diabetes and endocrinology is being shaped by innovation, technology, and multidisciplinary collaboration. This track will explore emerging trends, next-generation therapies, and future healthcare solutions. It will highlight breakthroughs that have the potential to transform patient care. Experts will discuss the evolving landscape of endocrine medicine.

• Future Diabetes Therapies

• Regenerative Medicine

• Advanced Endocrine Technologies

• Next-Generation Healthcare Solutions

Market Analysis

The global diabetes and endocrinology market is experiencing significant growth, driven by the rising prevalence of diabetes, increasing metabolic disorders, an aging population, and growing awareness of preventive healthcare. The demand for advanced diagnostic tools, effective therapies, and personalized treatment approaches is contributing to continuous market expansion.

Technological advancements such as continuous glucose monitoring (CGM), insulin delivery systems, artificial intelligence-based healthcare solutions, digital diabetes platforms, and precision medicine are transforming diabetes and endocrine care. Increasing healthcare investments and improved access to innovative treatments are creating new opportunities across developed and emerging markets.

1. Global Diabetes and Endocrinology Market Growth (2024–2033)

The global diabetes and endocrinology market is projected to experience significant growth between 2024 and 2033, driven by the increasing prevalence of diabetes, rising metabolic disorders, and the growing demand for advanced healthcare solutions. Technological advancements, innovative therapies, and improved disease management strategies are accelerating market expansion worldwide. The increasing burden of diabetes-related complications has strengthened the need for effective diagnostic tools, personalized treatments, and preventive care approaches. Rising healthcare investments and expanding access to diabetes and endocrine services are creating new opportunities across developed and emerging economies. Growing awareness of early diagnosis and lifestyle management continues to support sustained market growth.

2. Key Drivers of Market Growth by 2033

Key drivers supporting the growth of the diabetes and endocrinology market include the rising prevalence of diabetes, obesity, metabolic disorders, and endocrine-related conditions worldwide. Additional factors such as continuous glucose monitoring, digital diabetes management, artificial intelligence-based healthcare solutions, novel therapeutic developments, insulin delivery technologies, and precision medicine approaches are significantly contributing to market expansion. Increasing adoption of personalized treatment strategies and advanced diagnostic tools is accelerating innovation in diabetes and endocrine care. Government initiatives focused on diabetes prevention, awareness, and healthcare accessibility are improving patient outcomes globally. Continuous research and technological advancements are expected to further enhance disease management and transform the future of endocrine healthcare.

Participation / Presentation

Oral Presentation

Oral presentations at DIABETES MEET 2027 are open to research-based, clinical, theoretical, and professional topics related to Diabetes, Endocrinology, Metabolism, and Hormonal Health. Physicians, endocrinologists, diabetologists, researchers, and healthcare professionals are invited to share their expertise, research outcomes, and clinical experiences with a global audience.

Speaker Slot: 30 minutes total (20–25 minutes presentation+moderated Q&A)
Keynote Slot: 40–45 minutes with additional discussion time

Workshop Presentation

Workshops at DIABETES MEET 2027 will focus on advanced clinical practices, diabetes management strategies, emerging technologies, therapeutic innovations, and practical approaches in endocrinology and metabolic healthcare.

Duration: 45–50 minutes

Interactive workshops and team-based presentations are encouraged to promote knowledge sharing and collaborative learning among healthcare professionals.

Poster Presentation

The Poster Competition at DIABETES MEET 2027 provides an excellent platform for students, researchers, clinicians, and early-career professionals to present original research and innovative findings in diabetes and endocrinology.

Presentation Time: 5–7 minutes including Q&A

 • Judges may ask questions during evaluation.
 • Posters must be printed according to conference guidelines.

This competition enables emerging researchers to gain global visibility, receive expert feedback, and engage in interdisciplinary scientific discussions.

Webinar Presentation

For participants unable to attend in person, DIABETES MEET 2027 offers a webinar presentation option. Presenters can submit pre-recorded video presentations to be included in the official virtual conference sessions, allowing worldwide participation and knowledge exchange.

E-Poster Presentation

E-Posters will be displayed on the DIABETES MEET 2027 virtual conference platform. Accepted abstracts will be featured in the conference proceedings and may be included in relevant scientific publications with indexing opportunities.

Exhibition – DIABETES MEET 2027

The Exhibition Pavilion at DIABETES MEET 2027 provides an ideal platform for organizations to showcase innovations in diabetes care, endocrine diagnostics, medical technologies, pharmaceuticals, digital health solutions, and healthcare services.

Exhibitors Include:
• Diabetes Technology Companies
• Continuous Glucose Monitoring (CGM) Manufacturers
• Insulin Delivery System Providers
• Pharmaceutical and Biotechnology Companies
• Healthcare Organizations and Hospitals
• Diagnostic Equipment Manufacturers
• Digital Health and AI Solution Providers
• Clinical Research Organizations
• Academic and Research Institutions
• Industry Professionals and Business Delegates

The exhibition offers opportunities to present innovative solutions, build professional collaborations, expand industry networks, and enhance visibility within the global diabetes and endocrinology community.

For exhibition inquiries: meevents@memeetings.com

Advertisement

Advertising in the DIABETES MEET 2027 program guide ensures long-term visibility among delegates, researchers, clinicians, and industry leaders.

For advertisement opportunities and pricing, contact: meevents@memeetings.com

Sponsorship

Become a premium sponsor of DIABETES MEET 2027 and benefit from high-impact branding, networking, and engagement opportunities throughout the conference.

Communication Instructions

Please whitelist meevents@memeetings.com

• If no confirmation is received within 48 hours of registration or inquiry, please contact the conference coordinator.
• Check your spam/junk folder before reaching out.

Group Registration Discounts

DIABETES MEET 2027 offers discounted group registration rates. Email the registration team for details and eligibility requirements.

Important Registration Information

To ensure smooth coordination:

• Include your mobile number in your registration form and abstract submission.
• This allows rapid communication for updates or clarifications.

For general inquiries regarding DIABETES MEET 2027, contact meevents@memeetings.com

Abstract Submission Guidelines – DIABETES MEET 2027

•  Submit abstracts using the ABSTRACT SUBMISSION link.

• Abstracts must be in English (250–300 words) with a presenter biography (100–120 words).

• Submissions are welcome in all diabetes and endocrinology-related areas, including diabetes management, endocrinology, metabolic disorders, obesity, diabetes technology, diabetic complications, thyroid disorders, pediatric endocrinology, reproductive endocrinology, endocrine oncology, precision medicine, and digital healthcare innovations.

• Presenting authors must provide their name, affiliation, country, phone number, email address, and photograph.
• Co-authors must include full names and institutional affiliations.

• All abstracts will be reviewed by the DIABETES MEET 2027 Scientific Review  Committee.

• Accepted presenters must complete registration and pay the applicable conference fee.
• Please ensure all submitted information is accurate, as it will appear exactly as provided in the conference program and journal.

Complete your registration through the Online Registration link.

Visa Guidelines – DIABETES MEET 2027

The organizing committee does not process visas but can issue supporting documents, including:

• Letter of Invitation
• Letter of Abstract Acceptance
• Registration Payment Receipt

Only registered participants will receive official invitation letters.

Attendees may be required to submit:

• Passport Copy
• Date of Birth
• Residential Address
• Mobile Number
• Photograph

For visa-related inquiries, please contact the Program Manager at meevents@memeetings.com

Past Conference

The 6^th Annual Summit on Diabetes and Endocrinology (DIABETES 2026) was held on August 20–21, 2026, in Paris, France, bringing together endocrinologists, diabetologists, researchers, clinicians, academicians, healthcare professionals, and industry experts from around the world to exchange knowledge and discuss the latest advancements in diabetes and endocrine care. The conference successfully featured keynote presentations, oral and poster sessions, workshops, and panel discussions covering diabetes management, endocrinology, metabolic disorders, diabetes technology, innovative therapies, and emerging approaches shaping the future of diabetes and endocrine healthcare. The scientific program provided a valuable platform for collaboration, knowledge sharing, and exploring new developments in research and clinical practice.